In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mefenamic acid [USAN:INN:BAN:JAN] Drug Master File in Korea (Mefenamic acid [USAN:INN:BAN:JAN] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mefenamic acid [USAN:INN:BAN:JAN]. The MFDS reviews the Mefenamic acid [USAN:INN:BAN:JAN] KDMF as part of the drug registration process and uses the information provided in the Mefenamic acid [USAN:INN:BAN:JAN] KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mefenamic acid [USAN:INN:BAN:JAN] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mefenamic acid [USAN:INN:BAN:JAN] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mefenamic acid [USAN:INN:BAN:JAN] suppliers with KDMF on PharmaCompass.